Vasospasm in Aneurysmal Subarachnoid Hemorrhage: Diagnosis, Prevention, and Management

Neuroimaging Clinics of North America

Volumn 16, Issue 3, 2006, Pages 483-496

  Janardhan, Vallabh ^a   Biondi, Alessandra ^a   Riina, Howard A ^a   Sanelli, Pina C ^a   Stieg, Philip E ^a   Gobin, Y Pierre ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CLAZOSENTAN; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM SULFATE; N METHYL DEXTRO ASPARTIC ACID; NIMODIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; SIMVASTATIN;

ANEURYSM; ANGIOGRAPHY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; FIBRINOLYSIS; FLUID THERAPY; HUMAN; HYPONATREMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; REVIEW; SUBARACHNOID HEMORRHAGE;

HUMANS; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 33747787992     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2006.05.003     Document Type: Review

References (54)

1. Macdonald L.R., and Weir B. Epidemiology. Cerebral vasospasm (2001), Academic Press, San Diego (CA) 17-43
2. Linn F.H., Rinkel G.J., Algra A., et al. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 27 4 (1996) 625-629
3. Macdonald L.R., and Weir B. Radiology. Cerebral vasospasm (2001), Academic Press, San Diego (CA) 175-220
4. Fisher C.M., Kistler J.P., and Davis J.M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6 (1980) 1-9
5. Sloan M.A., Alexandrov A.V., Tegeler C.H., et al. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 62 9 (2004) 1468-1481
6. Lovblad K.O., el-Koussy M., Guzman R., et al. Diffusion-weighted and perfusion-weighted MR of cerebral vasospasm. Acta Neurochir Suppl (Wien) 77 (2001) 121-126
7. Harrigan M.R., Magnano C.R., Guterman L.R., et al. Computed tomographic perfusion in the management of aneurysmal subarachnoid hemorrhage: new application of an existent technique. Neurosurgery 56 (2005) 304-317
8. Clyde B.L., Resnick D.K., Yonas H., et al. The relationship of blood velocity as measured by transcranial Doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage. Neurosurgery 38 (1996) 896-904
9. Powers W.J.Z.A. The use of positron emission tomography in cerebrovascular disease. Neuroimaging Clin N Am 13 (2003) 741-758
10. Egge A., Sjoholm H., Waterloo K., et al. Serial single-photon emission computed tomographic and transcranial Doppler measurements for evaluation of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 57 (2005) 237-242
11. Hoelper B.M., Alessandri B., Heimann A., et al. Brain oxygen monitoring: in vitro accuracy, long-term drift and response-time of Licox- and Neurotrend sensors. Acta Neurochir (Wien) 147 (2005) 767-774
12. Vath A., Kunze E., Roosen K., et al. Therapeutic aspects of brain tissue pO2 monitoring after subarachnoid hemorrhage. Acta Neurochir Suppl (Wien) 81 (2002) 307-309
13. Charbel F.T., Du X., Hoffman W.E., et al. Brain tissue PO(2), PCO(2), and pH during cerebral vasospasm. Surg Neurol 54 (2000) 432-437
14. Unterberg A.W., Sakowitz O.W., Sarrafzadeh A.S., et al. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 94 (2001) 740-749
15. Sarrafzadeh A.S., Haux D., Ludemann L., et al. Cerebral ischemia in aneurysmal subarachnoid hemorrhage: a correlative microdialysis-PET study. Stroke 35 (2004) 638-643
16. Peerdeman S.M., van Tulder M.W., and Vandertop W.P. Cerebral microdialysis as a monitoring method in subarachnoid hemorrhage patients, and correlation with clinical events-a systematic review. J Neurol 250 (2003) 797-805
17. Lennihan L., Mayer S.A., Fink M.E., et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31 (2000) 383-391
18. Qureshi A.I., Suri M.F., Sung G.Y., et al. Prognostic significance of hypernatremia and hyponatremia among patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 50 (2002) 749-755
19. McGirt M.J., Blessing R., Nimjee S.M., et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery 54 (2004) 1369-1373
20. Hasan D., Lindsay K.W., Wijdicks E.F., et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke 20 (1989) 1156-1161
21. Janardhan V., Ougorets I., Katz J.M., et al. Prospective protocol for management of hyponatremia in nontraumatic subarachnoid hemorrhage patients with hypertonic saline (3%) infusion. Stroke 36 (2005) 451
22. Macdonald L.R., and Weir B. Medical aspects of vasospasm. Cerebral vasospasm (2001), Academic Press, San Diego, (CA) 353-458
23. Pickard J.D., Murray G.D., Illingworth R., et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298 (1989) 636-642
24. Janardhan V., and Qureshi A. Mechanisms of ischemic brain injury. Curr Cardiol Rep 6 (2004) 117-123
25. van den Bergh W.M., Algra A., van Kooten F., et al., for the MASH study group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36 (2005) 1011-1015
26. Lynch J.R., Wang H., McGirt M.J., et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 36 (2005) 2024-2026
27. McGirt M.J., Lynch J.R., Parra A., et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke 33 (2002) 2950-2956
28. Vajkoczy P., Meyer B., Weidauer S., et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg 103 (2005) 9-17
29. Frazier J.L., Pradilla G., Wang P.P., et al. Inhibition of cerebral vasospasm by intracranial delivery of ibuprofen from a controlled-release polymer in a rabbit model of subarachnoid hemorrhage. J Neurosurg 101 (2004) 93-98
30. Juvela S. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg 82 (1995) 945-952
31. Hop J.W., Rinkel G.J., Algra A., et al. Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage. Neurology 54 (2000) 872-878
32. Hamada J., Kai Y., Morioka M., et al. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study. Stroke 34 (2003) 2549-2554
33. Naff N.J., Carhuapoma J.R., Williams M.A., et al. Treatment of intraventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 31 (2000) 841-847
34. Treggiari M.M., Walder B., Suter P.M., et al. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98 (2003) 978-984
35. Rosenwasser R.H., Armonda R.A., Thomas J.E., et al. Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 44 (1999) 975-979
36. Kassell N.F., Helm G., Simmons N., et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77 (1992) 848-852
37. Carhuapoma J.R., Qureshi A.I., Tamargo R.J., et al. Intra-arterial papaverine-induced seizures: case report and review of the literature. Surg Neurol 56 (2001) 159-163
38. Cross III D.T., Moran C.J., Angtuaco E.E., et al. Intracranial pressure monitoring during intra-arterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 19 (1998) 1319-1323
39. Biondi A., Ricciardi G.K., Puybasset L., et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol 25 (2004) 1067-1076
40. Badjatia N., Topcuoglu M.A., Pryor J.C., et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. AJNR Am J Neuroradiol 25 (2004) 819-826
41. Feng L., Fitzsimmons B.F., Young W.L., et al. Intra-arterial administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol 23 (2002) 1284-1290
42. Yoshida K., Watanabe H., and Nakamura S. Intra-arterial injection of amrinone for vasospasm induced by subarachnoid hemorrhage. AJNR Am J Neuroradiol 18 (1997) 492-496
43. Arakawa Y., Kikuta K., Hojo M., et al. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery 48 (2001) 723-728
44. Terada T., Kinoshita Y., Yokote H., et al. The effect of endovascular therapy for cerebral arterial spasm, its limitation and pitfalls. Acta Neurochir (Wien) 139 (1997) 227-234
45. Elliott J.P., Newell D.W., Lam D.J., et al. Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 88 (1998) 277-284
46. Eskridge J.M., McAuliffe W., Song J.K., et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurgery 42 (1998) 510-516
47. Zubkov Y.N., Nikiforov B.M., and Shustin V.A. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta Neurochir (Wien) 70 (1984) 65-79
48. Megyesi J.F., Findlay J.M., Vollrath B., et al. In vivo angioplasty prevents the development of vasospasm in canine carotid arteries. Pharmacological and morphological analyses. Stroke 28 (1997) 1216-1224
49. Firlik A.D., Kaufmann A.M., Jungreis C.A., et al. Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 86 (1997) 830-839
50. Hoelper B.M., Hofmann E., Sporleder R., et al. Transluminal balloon angioplasty improves brain tissue oxygenation and metabolism in severe vasospasm after aneurysmal subarachnoid hemorrhage: case report. Neurosurgery 52 (2003) 970-974
51. Le Roux P.D., Newell D.W., Eskridge J., et al. Severe symptomatic vasospasm: the role of immediate postoperative angioplasty. J Neurosurg 80 (1994) 224-229
52. Coyne T.J., Montanera W.J., Macdonald R.L., et al. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg 37 (1994) 391-396
53. Bejjani G.K., Bank W.O., Olan W.J., et al. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42 (1998) 979-986
54. Iseda T., Nakano S., Yoneyama T., et al. Angiographic cerebral circulation time before and after endovascular therapy for symptomatic vasospasm. Clin Radiol 55 (2000) 679-683